vs

Side-by-side financial comparison of CaliberCos Inc. (CWD) and Lakeside Holding Ltd (LSH). Click either name above to swap in a different company.

Lakeside Holding Ltd is the larger business by last-quarter revenue ($7.0M vs $4.1M, roughly 1.7× CaliberCos Inc.). Lakeside Holding Ltd runs the higher net margin — -22.6% vs -188.3%, a 165.7% gap on every dollar of revenue. On growth, Lakeside Holding Ltd posted the faster year-over-year revenue change (95.0% vs -52.5%).

CaliberCos Inc. is a U.S.-headquartered alternative asset management firm focused primarily on real estate investments. It offers a diverse suite of investment vehicles covering commercial, residential, and industrial real estate assets, serving institutional investors, high-net-worth individuals, and retail clients across North America. It also delivers asset management, property operation, and value-add real estate development services to support consistent long-term returns for investors.

Lakeside Press was a Chicago publishing imprint under which the RR Donnelley Company produced fine books as well as mail order catalogs, telephone directories, encyclopedias, and advertising. The Press was best known for its high quality editions for the Chicago Caxton Club as well as the Lakeside Classics, a series of fine reprints.

CWD vs LSH — Head-to-Head

Bigger by revenue
LSH
LSH
1.7× larger
LSH
$7.0M
$4.1M
CWD
Growing faster (revenue YoY)
LSH
LSH
+147.5% gap
LSH
95.0%
-52.5%
CWD
Higher net margin
LSH
LSH
165.7% more per $
LSH
-22.6%
-188.3%
CWD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CWD
CWD
LSH
LSH
Revenue
$4.1M
$7.0M
Net Profit
$-7.7M
$-1.6M
Gross Margin
27.2%
Operating Margin
-196.6%
-21.3%
Net Margin
-188.3%
-22.6%
Revenue YoY
-52.5%
95.0%
Net Profit YoY
32.2%
18.7%
EPS (diluted)
$1.95
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CWD
CWD
LSH
LSH
Q4 25
$4.1M
$7.0M
Q3 25
$3.6M
$6.1M
Q2 25
$5.1M
$6.3M
Q1 25
$7.3M
$3.8M
Q4 24
$8.7M
$3.6M
Q3 24
$11.3M
$4.1M
Q2 24
$8.2M
Q1 24
$23.0M
Net Profit
CWD
CWD
LSH
LSH
Q4 25
$-7.7M
$-1.6M
Q3 25
$-4.4M
$-1.4M
Q2 25
$-5.3M
$-893.1K
Q1 25
$-4.4M
$-1.1M
Q4 24
$-11.4M
$-1.9M
Q3 24
$146.0K
$-1.3M
Q2 24
$-4.7M
Q1 24
$-3.8M
Gross Margin
CWD
CWD
LSH
LSH
Q4 25
27.2%
Q3 25
18.2%
Q2 25
26.7%
Q1 25
18.8%
Q4 24
-1.2%
Q3 24
12.8%
Q2 24
Q1 24
Operating Margin
CWD
CWD
LSH
LSH
Q4 25
-196.6%
-21.3%
Q3 25
-129.6%
-20.8%
Q2 25
-112.4%
-8.9%
Q1 25
-62.7%
-28.2%
Q4 24
-236.8%
-55.6%
Q3 24
0.0%
-32.5%
Q2 24
-65.0%
Q1 24
-22.9%
Net Margin
CWD
CWD
LSH
LSH
Q4 25
-188.3%
-22.6%
Q3 25
-120.2%
-22.2%
Q2 25
-104.5%
-14.2%
Q1 25
-60.7%
-28.2%
Q4 24
-247.6%
-54.1%
Q3 24
1.3%
-32.7%
Q2 24
-57.8%
Q1 24
-16.6%
EPS (diluted)
CWD
CWD
LSH
LSH
Q4 25
$1.95
$-0.08
Q3 25
$-1.65
$-0.09
Q2 25
$-4.15
$-0.11
Q1 25
$-3.85
$-0.14
Q4 24
$-10.15
$-0.26
Q3 24
$0.12
$-0.18
Q2 24
$-4.34
Q1 24
$-3.53

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CWD
CWD
LSH
LSH
Cash + ST InvestmentsLiquidity on hand
$2.9M
$1.6M
Total DebtLower is stronger
$2.4M
Stockholders' EquityBook value
$1.3M
$12.2M
Total Assets
$135.4M
$24.3M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CWD
CWD
LSH
LSH
Q4 25
$2.9M
$1.6M
Q3 25
$10.9M
$4.5M
Q2 25
$683.0K
$5.0M
Q1 25
$1.6M
$1.5M
Q4 24
$2.3M
$1.1M
Q3 24
$1.6M
$2.7M
Q2 24
$1.8M
Q1 24
$2.1M
Total Debt
CWD
CWD
LSH
LSH
Q4 25
$2.4M
Q3 25
$2.4M
Q2 25
$1.4M
Q1 25
$774.2K
Q4 24
$784.8K
Q3 24
$589.9K
Q2 24
Q1 24
Stockholders' Equity
CWD
CWD
LSH
LSH
Q4 25
$1.3M
$12.2M
Q3 25
$4.2M
$7.0M
Q2 25
$-19.9M
$2.8M
Q1 25
$-15.8M
$749.8K
Q4 24
$-12.6M
$1.6M
Q3 24
$-3.8M
$3.6M
Q2 24
$-4.7M
Q1 24
$-745.0K
Total Assets
CWD
CWD
LSH
LSH
Q4 25
$135.4M
$24.3M
Q3 25
$82.6M
$18.6M
Q2 25
$59.3M
$14.4M
Q1 25
$103.6M
$9.9M
Q4 24
$105.5M
$9.8M
Q3 24
$158.6M
$10.8M
Q2 24
$195.2M
Q1 24
$201.5M
Debt / Equity
CWD
CWD
LSH
LSH
Q4 25
0.20×
Q3 25
0.35×
Q2 25
0.48×
Q1 25
1.03×
Q4 24
0.48×
Q3 24
0.16×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CWD
CWD
LSH
LSH
Operating Cash FlowLast quarter
$-12.1M
$-453.5K
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CWD
CWD
LSH
LSH
Q4 25
$-12.1M
$-453.5K
Q3 25
$-4.6M
$-4.0M
Q2 25
$-1.2M
$-483.7K
Q1 25
$-1.7M
$-238.3K
Q4 24
$555.0K
$-530.2K
Q3 24
$-74.0K
$-1.4M
Q2 24
$1.4M
Q1 24
$-1.5M
Free Cash Flow
CWD
CWD
LSH
LSH
Q4 25
Q3 25
Q2 25
$-497.4K
Q1 25
Q4 24
$-560.5K
Q3 24
$-1.4M
Q2 24
Q1 24
FCF Margin
CWD
CWD
LSH
LSH
Q4 25
Q3 25
Q2 25
-7.9%
Q1 25
Q4 24
-15.6%
Q3 24
-34.5%
Q2 24
Q1 24
Capex Intensity
CWD
CWD
LSH
LSH
Q4 25
Q3 25
Q2 25
0.2%
Q1 25
0.0%
Q4 24
0.8%
Q3 24
0.1%
Q2 24
Q1 24
Cash Conversion
CWD
CWD
LSH
LSH
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
-0.51×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CWD
CWD

Segment breakdown not available.

LSH
LSH

Transferred Over Time$4.6M65%
Distribution Of Pharmaceutical Products$2.4M35%

Related Comparisons